James H Tabibian

Summary

Affiliation: Mayo Clinic
Country: USA

Publications

  1. ncbi Primary sclerosing cholangitis: a review and update on therapeutic developments
    James H Tabibian
    Division of Gastroenterology and Hepatology, Mayo Clinic, 200 First St SW, Rochester, MN 55905, USA
    Expert Rev Gastroenterol Hepatol 7:103-14. 2013
  2. ncbi Sirolimus may be associated with early recurrence of biliary obstruction in liver transplant patients undergoing endoscopic stenting of biliary strictures
    James H Tabibian
    Department of Medicine, Johns Hopkins Medical Institutions, Baltimore, Maryland, USA
    Ann Hepatol 10:270-6. 2011
  3. ncbi Nonalcoholic fatty liver disease across ethno-racial groups: do Asian-American adults represent a new at-risk population?
    James H Tabibian
    Department of Medicine, Johns Hopkins Hospital, Baltimore, Maryland, USA
    J Gastroenterol Hepatol 26:501-9. 2011

Detail Information

Publications3

  1. ncbi Primary sclerosing cholangitis: a review and update on therapeutic developments
    James H Tabibian
    Division of Gastroenterology and Hepatology, Mayo Clinic, 200 First St SW, Rochester, MN 55905, USA
    Expert Rev Gastroenterol Hepatol 7:103-14. 2013
    ..The authors herein provide a review of previously tested pharmacologic agents, discuss emerging fundamental concepts and present viewpoints regarding how identifying therapies for PSC may evolve over the next several years...
  2. ncbi Sirolimus may be associated with early recurrence of biliary obstruction in liver transplant patients undergoing endoscopic stenting of biliary strictures
    James H Tabibian
    Department of Medicine, Johns Hopkins Medical Institutions, Baltimore, Maryland, USA
    Ann Hepatol 10:270-6. 2011
    ..We evaluated the relationship between prednisone or sirolimus use and early recurrence of biliary obstruction given their negative effects on collagen production and cholangiocyte regeneration...
  3. ncbi Nonalcoholic fatty liver disease across ethno-racial groups: do Asian-American adults represent a new at-risk population?
    James H Tabibian
    Department of Medicine, Johns Hopkins Hospital, Baltimore, Maryland, USA
    J Gastroenterol Hepatol 26:501-9. 2011
    ..We explored clinical, laboratory, and histological features of NAFLD as well as risk factors for histologically advanced disease among under-represented ethno-racial groups...